Bioavailability of methaqualone. 1973

R D Smyth, and J K Lee, and A Polk, and P B Chemburkar, and A M Savacool

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D008297 Male Males
D008702 Methaqualone A quinazoline derivative with hypnotic and sedative properties. It has been withdrawn from the market in many countries because of problems with abuse. (From Martindale, The Extra Pharmacopoeia, 30th ed, p604) Metolquizolone,Ortonal,Methaqualone Hydrochloride,Optimil,Quaalude,Hydrochloride, Methaqualone
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002214 Capsules Hard or soft soluble containers used for the oral administration of medicine. Capsule,Microcapsule,Microcapsules
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001702 Biopharmaceutics The study of the physical and chemical properties of a drug and its dosage form as related to the onset, duration, and intensity of its action. Pharmaceutics,Pharmaceutic

Related Publications

R D Smyth, and J K Lee, and A Polk, and P B Chemburkar, and A M Savacool
January 1973, Clinical toxicology,
R D Smyth, and J K Lee, and A Polk, and P B Chemburkar, and A M Savacool
September 1978, Journal of pharmaceutical sciences,
R D Smyth, and J K Lee, and A Polk, and P B Chemburkar, and A M Savacool
November 1973, The American journal of nursing,
R D Smyth, and J K Lee, and A Polk, and P B Chemburkar, and A M Savacool
January 1969, British medical journal,
R D Smyth, and J K Lee, and A Polk, and P B Chemburkar, and A M Savacool
June 1973, JAMA,
R D Smyth, and J K Lee, and A Polk, and P B Chemburkar, and A M Savacool
April 1988, International clinical psychopharmacology,
R D Smyth, and J K Lee, and A Polk, and P B Chemburkar, and A M Savacool
September 1973, Acta pharmaceutica Suecica,
R D Smyth, and J K Lee, and A Polk, and P B Chemburkar, and A M Savacool
November 1981, North Carolina medical journal,
R D Smyth, and J K Lee, and A Polk, and P B Chemburkar, and A M Savacool
July 1973, Archives of general psychiatry,
R D Smyth, and J K Lee, and A Polk, and P B Chemburkar, and A M Savacool
May 1974, The Journal of the Maine Medical Association,
Copied contents to your clipboard!